ANALOG DEVICES INC quarterly report, Q1 FY2021

Analog Devices, Inc. Form 10-Q Summary

Business Context and Reporting Period

Analog Devices designs, develops, manufactures and markets integrated circuits and reports one operating segment. This unaudited report covers the three months ended January 30, 2021, the first quarter of fiscal 2021, compared with the three months ended February 1, 2020. Results are not necessarily indicative of full-year performance.

Financial Performance and Position

Metric	Q1 FY2021	Q1 FY2020	Change
Revenue	$1.558 billion	$1.304 billion	Up 20%
Gross margin	$1.045 billion; 67.1%	$848.1 million; 65.1%	Up 200 basis points
Operating income	$463.9 million; 29.8% of revenue	$273.4 million; 21.0%	Up 70%
Net income	$388.5 million; 24.9% of revenue	$203.9 million; 15.6%	Up 91%
Diluted EPS	$1.04	$0.55	Up $0.49
Cash flow from operations	$427.9 million	$349.6 million	Up $78.3 million

Revenue growth reflected higher demand across all end markets: Industrial $855.5 million, up 24%; Communications $281.0 million, up 16%; Automotive $245.3 million, up 19%; and Consumer $176.7 million, up 5%.
Gross margin expansion primarily reflected higher factory utilization resulting from increased customer demand.
Research and development expense rose 12% to $288.2 million, while selling, marketing, general and administrative expense declined 7% to $185.3 million. The comparison benefited from a $40.0 million charitable contribution in the prior-year quarter, partly offset by $15.2 million of Maxim transaction costs in the current quarter.
Nonoperating expense declined to $27.2 million from $47.2 million, primarily because of a $16.2 million gain on other investments.
The effective tax rate was 11.0%, compared with 9.9%, and remained below the 21% U.S. statutory rate because of lower foreign tax rates.

Cash Flow, Liquidity and Debt

Cash and cash equivalents were $1.048 billion at January 30, 2021, compared with $1.056 billion at October 31, 2020. Approximately $245.8 million was held in the United States, with the balance held by foreign subsidiaries.
Investing cash outflows were $75.1 million, including $67.4 million of capital expenditures, $22.5 million for an asset acquisition and $2.4 million for acquisitions, partly offset by $18.6 million of investment proceeds.
Financing cash outflows were $363.8 million, including $229.2 million of dividends and $157.1 million of common-stock repurchases.
Total debt principal outstanding was $5.175 billion, consisting of a $925.0 million term loan and $4.250 billion of senior unsecured notes. Current debt on the balance sheet was $399.2 million and long-term debt was $4.747 billion.
The company had a $1.25 billion unsecured revolving credit facility expiring June 28, 2024 and was in compliance with applicable debt and leverage covenants at quarter-end.
Management believes existing liquidity, operating cash flow and available financing are sufficient to fund operations, capital expenditures, research and development, Maxim transaction costs and dividends for at least the next twelve months.

Material Changes Versus the Prior Comparable Period

Revenue, operating income, net income and diluted EPS increased materially, supported by broad-based demand and improved manufacturing utilization.
Gross margin increased from 65.1% to 67.1%, while operating margin increased from 21.0% to 29.8%.
Operating cash flow increased 22%, despite unfavorable working-capital changes.
Shareholder returns increased: dividends paid rose to $229.2 million from $199.2 million, and share repurchases rose to $157.1 million from $106.0 million.
Accounts receivable increased 12% from October 31, 2020 to $827.0 million, while inventory increased 2% to $618.6 million.
The company adopted new credit-loss, income-tax and pension-disclosure accounting standards without a material effect on financial position or results.

Guidance, Outlook, Commentary and Risks

Fiscal 2021 capital expenditures are expected to be slightly above 4% of revenue and funded by cash on hand and operating cash flow. Management expects quarterly dividends to continue, subject to Board approval and business conditions.
The proposed acquisition of Maxim Integrated Products remained pending. The all-stock transaction provides 0.630 Analog Devices share for each Maxim share and had estimated consideration of approximately $27.0 billion based on the February 12, 2021 share price. Required shareholder approvals and U.S. antitrust waiting-period clearance had been obtained, but certain non-U.S. regulatory approvals remained outstanding.
Analog Devices could owe Maxim an $830.0 million regulatory termination fee if the merger is terminated in certain circumstances involving failure to obtain required regulatory approvals. The merger agreement could terminate if the transaction is not completed by July 12, 2021, subject to possible extensions.
COVID-19-related manufacturing and supply-chain conditions had generally stabilized, but management stated that future effects remain difficult to quantify and could include facility, workforce, transportation, supplier and customer disruptions.
The company plans to close its Hillview, California wafer facility in fiscal 2021 and its Singapore test facility in the fiscal year ending October 29, 2022, while transitioning production to other facilities and external providers. A Singapore facility with a carrying value of $22.2 million was classified as held for sale.
An Irish transfer-pricing assessment of approximately €43.0 million, or $52.0 million at January 30, 2021, excluding penalties and interest, remains under appeal. The company has not recorded an additional liability. An unfavorable resolution, including effects on other open years, could materially affect future tax expense and earnings.
Other key risks include semiconductor cyclicality, customer forecast and cancellation risk, reliance on third-party foundries and distributors, international operations and trade restrictions, foreign-exchange and interest-rate exposure, debt servicing, product liability and intellectual-property claims, and the execution and integration risks associated with the Maxim transaction.
Management reported effective disclosure controls and procedures and no material change in internal control over financial reporting during the quarter.

Most Important Facts for Investors to Verify

Whether the Maxim acquisition receives all remaining regulatory approvals, closes on schedule and produces the expected strategic and financial benefits.
The potential cash impact of the $830.0 million merger termination fee and ongoing transaction and integration costs.
Progress and costs associated with the Hillview and Singapore facility closures and manufacturing transfers.
The status and potential exposure from the Irish transfer-pricing assessment and other global tax audits.
Whether demand, factory utilization and gross-margin gains are sustained without excessive inventory or capacity constraints.
Debt maturities, refinancing plans and compliance with the revolving-credit leverage covenant, particularly in connection with the proposed Maxim transaction.
The effect of COVID-19, export restrictions involving China, supply-chain disruptions and distributor demand on future revenue and cash flow.